{
    "medicine_id": "b328af47a4984bd9ffad7be1d0e1304b8a3ed5b4",
    "platform_id": "DB05236",
    "metadata": {
        "name": "Eucrisa 20 mg 1g Ointment",
        "composition": "20 mg 1g ReN001",
        "clinical_particulars": {
            "therapeutic_indications": "For the treatment of stroke",
            "contraindications": {
                "disease": "NA",
                "pregnancy": "NA",
                "machine_ops": "NA",
                "pharmacodynamics": "ReN001 is a clonal human neural stem cell line which has been conditionally immortalized using the fusion transgene c mycERTAM to allow controlled expansion when cultured in the presence of 4 hydroxytamoxifen The cell line has been banked and fully characterized to assure there is genetic stability and no phenotypic drift with extended passages In vivo studies determined the ability of the cell line to survive after implantation into damaged brain and its efficacy in the reduction of chronic behavioural dysfunction after implantation into a rodent model of stroke damage A further study was conducted in this model and a dose dependent effect was observed on behavioural recovery No safety or toxicology issues were identified in in vivo studies with this cell line",
                "excipients": "NA",
                "incompatibilities": []
            }
        },
        "revision_date": "2023-05-14"
    }
}